Rx Tactical Rotation Fund

U.S. News evaluated 304 World Stock Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all FolioMetrix funds

See full World Stock rankings

See more fund rankings

Performance

The fund has returned 12.90 percent over the past year.

Trailing Returns Updated 02.28.2014
Year to date 1.4%
1 Year 12.9%
3 Years (Annualized) N/A
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more FMLAX performance

Summary

The investment seeks capital appreciation. The fund invests in no-load, institutional, and exchange-traded funds that are registered under the Investment Company Act of 1940 and not affiliated with the fund ("portfolio funds") or making direct investments in portfolio securities based upon institutional research, recommendations, and trading signals from investment model managers or other third-party research providers. The investments of the fund and portfolio funds will be comprised of equity securities principally consisting of common stock, preferred stock, convertible preferred stock, convertible bonds, and warrants.

Fees

Fees are High compared to funds in the same category.
Rx Tactical Rotation Fund has an expense ratio of 2.20 percent.

See more FMLAX fees

Risk

Risk is N/A compared to funds in the same category according to Morningstar.

See more FMLAX risk